Yinghua Lv

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Angiotensin Converting Enzyme

Top Venues

Chemical communications (Cambridge, England)

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Bingling Gao, Ke Yang, Manman Yang, Wendong Li, Tingli Jiang, Rong Gao, Yuxin Pei, Zhichao Pei, Yinghua Lv
A nanoplatform based on allylthiopurine bio-MOF and glycosylated AIE PARP inhibitor for cancer synthetic lethal therapy. Chemical communications (Cambridge, England) 60 (67) (2024)
Bingling Gao, Ke Yang, Manman Yang, Wendong Li, Tingli Jiang, Rong Gao, Yuxin Pei, Zhichao Pei, Yinghua Lv
A nanoplatform based on allylthiopurine bio-MOF and glycosylated AIE PARP inhibitor for cancer synthetic lethal therapy. Chemical communications (Cambridge, England) (2024)
Ke Yang, Ke Ma, Manman Yang, Yinghua Lv, Yuxin Pei, Zhichao Pei
Supramolecular nanoprodrug based on a chloride channel blocker and glycosylated pillar[5]arenes for targeted chemoresistance cancer therapy. Chemical communications (Cambridge, England) 59 (25) (2023)
Ke Yang, Ke Ma, Manman Yang, Yinghua Lv, Yuxin Pei, Zhichao Pei
Supramolecular nanoprodrug based on a chloride channel blocker and glycosylated pillar[5]arenes for targeted chemoresistance cancer therapy. Chemical communications (Cambridge, England) 59 (25) (2023)
Jiaxuan Li, Baifei Hu, Zelong Chen, Jiahui Li, Wenjuan Jin, Yi Wang, Yichen Wan, Yinghua Lv, Yuxin Pei, Hong-Tao Liu, Zhichao Pei
Mn(iii)-mediated carbon-centered radicals generate an enhanced immunotherapeutic effect. Chemical science 15 (2) (2023)
Ke Yang, Ke Ma, Manman Yang, Yinghua Lv, Yuxin Pei, Zhichao Pei
Supramolecular nanoprodrug based on a chloride channel blocker and glycosylated pillar[5]arenes for targeted chemoresistance cancer therapy. Chemical communications (Cambridge, England) (2023)
Jiaxuan Li, Baifei Hu, Zelong Chen, Jiahui Li, Wenjuan Jin, Yi Wang, Yichen Wan, Yinghua Lv, Yuxin Pei, Hong-Tao Liu, Zhichao Pei
Mn(iii)-mediated carbon-centered radicals generate an enhanced immunotherapeutic effect. Chemical science 15 (2) (2023)
Manman Yang, Ke Yang, Bingling Gao, Peng Wang, Tianjiao Li, Yi Zheng, Yuxin Pei, Zhichao Pei, Yinghua Lv
A supramolecular nano-delivery system based on AIE PARP inhibitor prodrug and glycosylated pillar[5]arene for drug-resistance therapy. Chemical communications (Cambridge, England) 58 (79) (2022)